Fire breaks out in GSK Pharma's manufacturing unit - Know how much loss was incurred?

News Topical, Digital Desk : Pharma company GlaxoSmithKline Pharmaceuticals Limited (GSK Pharma) has informed that a fire incident at the company's contract manufacturing facility has caused a production disruption. The company said that it is assessing the impact of the incident and is working closely with the site to resume operations. GSK Pharma is a global healthcare company specializing in vaccines, specialty medicines and general medicines. It operates under the British multinational pharma corporation GSK PLC headquartered in London.

GSK Pharma India, a subsidiary of GSK PLC, focuses on the development and marketing of vaccines and medicines with a special emphasis on infectious diseases, HIV, oncology and immunology. 

Stock Performance The company's stock closed 1.70 per cent lower at Rs 2,830 on Friday. In the last one year, the company's stock has seen a gain of 39.93 per cent. The stock's 52-week high is Rs 3,148. 

Read More: FII/FPI & DII Data: On Friday 16th May, FII broke a big record - know what DIIs did